IDEAYA Biosciences, Inc. (IDYA) Stock Analysis

Free AI-powered analysis and research for IDEAYA Biosciences, Inc. stock

Sector: Healthcare

Analyze IDEAYA Biosciences, Inc. (IDYA) Stock

IDEAYA Biosciences, Inc. (IDYA) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into IDYA stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for IDEAYA Biosciences, Inc. stock.

Analyze IDYA Now →

📰 Latest Update

IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program

Thu, April 30, 2026 at 10:00 AM UTC 2 min read

IDEAYA Biosciences announced it will initiate a New Drug Application (NDA) submission for darovasertib, based on results from the OptimUM-02 trial, under the FDA's Real-time Oncology Review (RTOR) program. This step is significant for investors as it could expedite the approval process for a promising cancer treatment, potentially enhancing the company's market position and driving future revenue growth. The move reflects IDEAYA's commitment to advancing its oncology pipeline.

Read full article →